Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

HORKÝ Ondřej MAYER Jiří KABLÁSKOVÁ Lenka RÁZGA Filip KREJČÍ Marta KISSOVÁ Jarmila BORSKÝ Marek JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana

Year of publication 2010
Type Article in Periodical
Magazine / Source International Journal of Laboratory Hematology
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords microchimerism; chimerism; real-time PCR; relapse; acute myeloid leukemia
Description Using real-time PCR (RQ-PCR), we compare peripheral blood samples obtained from patients with acute myeloid leukemia (AML) before hematological relapse and those taken during complete remission. By comparison of these two groups, we describe microchimerism dynamics clearly connected with imminent AML relapse. Mere reappearance of autologous hematopoiesis within patients with complete donor chimerism is alarming, and another sample with further increase confirms ongoing relapse. In case of patients with continuous microchimerism, another two consecutive samples with increasing trend are required. RQ-PCR predicted a significantly higher number of hematological relapses (87% vs. 39%) with a median anticipation period of 33 days, 26 days earlier than conventional PCR (P = 0.0002). Moreover, the outcome of microchimerism dynamics was in complete agreement with monitoring of minimal residual disease when analyzed from the same cell compartment.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info